Structures by: Kaneda Y.
Total: 9
C14H28O4Si
C14H28O4Si
ACS Medicinal Chemistry Letters (2020)
a=7.45990(10)Å b=21.2716(2)Å c=31.6447(3)Å
α=90° β=90° γ=90°
C74H64Cl12N4Mo2O4P4Pd2
C74H64Cl12N4Mo2O4P4Pd2
Journal of the American Chemical Society (1998) 120, 12151-12152
a=26.72(1)Å b=12.50(1)Å c=24.98(1)Å
α=90° β=104.27(3)° γ=90°
C92H76Mo2N12O7P4Pd2
C92H76Mo2N12O7P4Pd2
Journal of the American Chemical Society (1998) 120, 12151-12152
a=14.844(7)Å b=21.276(7)Å c=30.941(6)Å
α=90° β=90.24(3)° γ=90°
(C76H56Mo2N8O4P4Pd2),2(C4H8O),1(C4H10O)
(C76H56Mo2N8O4P4Pd2),2(C4H8O),1(C4H10O)
Inorganic Chemistry (2009) 48, 1879-1886
a=18.53(2)Å b=20.23(5)Å c=12.242(14)Å
α=96.42(14)° β=108.60(11)° γ=102.00(16)°
C88H88Ir2Mo2N8O4P42,2(C24H20B11),C2H3N1,2(C4H10O1)
C88H88Ir2Mo2N8O4P42,2(C24H20B11),C2H3N1,2(C4H10O1)
Inorganic chemistry (2007) 46, 16 6702-6714
a=16.10926(18)Å b=26.5949(3)Å c=16.00206(19)Å
α=100.5946(3)° β=101.2461(5)° γ=77.3289(5)°
C70H52Cl2Ir2Mo2N4O6P4,2(C1H2Cl2)
C70H52Cl2Ir2Mo2N4O6P4,2(C1H2Cl2)
Inorganic chemistry (2007) 46, 16 6702-6714
a=31.0136(7)Å b=12.2081(3)Å c=19.8174(5)Å
α=90.00° β=106.6380(10)° γ=90.00°
(C104H88I2Ir2Mo2N8O4P42),2(BC24H201),3(C2H4Cl2),2(H2O)
(C104H88I2Ir2Mo2N8O4P42),2(BC24H201),3(C2H4Cl2),2(H2O)
Inorganic chemistry (2007) 46, 16 6702-6714
a=33.885(3)Å b=19.787(3)Å c=27.629(3)Å
α=90.00° β=126.749(4)° γ=90.00°
(C88H88Cl2Ir2Mo2N8O4P42),2(P1F61),2.83(C1H2Cl2)
(C88H88Cl2Ir2Mo2N8O4P42),2(P1F61),2.83(C1H2Cl2)
Inorganic chemistry (2007) 46, 16 6702-6714
a=30.4565(4)Å b=12.62185(16)Å c=30.7539(4)Å
α=90.00° β=115.3044(4)° γ=90.00°
(C104.78H90.34I1.22Ir2Mo2N8O4P42),2(BC24H201),3.25(CH2Cl2)
(C104.78H90.34I1.22Ir2Mo2N8O4P42),2(BC24H201),3.25(CH2Cl2)
Inorganic chemistry (2007) 46, 16 6702-6714
a=33.911(3)Å b=19.6687(18)Å c=27.350(2)Å
α=90.00° β=126.895(3)° γ=90.00°